Comparison · NCT00756613-2bc5aa4e
465 VADT Participants - Standard vs 465 VADT Participants -Intensive: The Long Term Effects of Intensive Glycemic Control in Type 2 Diabetes on the Secondary Outcome Cardiovascular Mortality.
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. 465 VADT Participants - Standard vs 465 VADT Participants -Intensive: The Long Term Effects of Intensive Glycemic Control in Type 2 Diabetes on the Secondary Outcome Cardiovascular Mortality. Trial comparisons, record NCT00756613-2bc5aa4e. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT00756613-2bc5aa4e
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.139 | 0.118 | 0.163 | wilson | |
| Risk in group 2 | 0.132 | 0.112 | 0.156 | wilson | |
| Risk difference, group 1 minus group 2 | 0.00676 | -0.0251 | 0.0385 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 1.05 | 0.832 | 1.33 | log | |
| Odds ratio, group 1 over group 2 | 1.06 | 0.808 | 1.39 | log | |
| Number needed to treat, for one more participant with the outcome on 465 VADT Participants - Standard than on 465 VADT Participants -Intensive | 148 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | 465 VADT Participants - Standard | The participants had previously participated in the VADT Cooperative Studies Program (CSP) #465 study in standard treatment group. | 125 | 899 | OG000 |
| Group 2 | 465 VADT Participants -Intensive | The participants had previously participated in the VADT Cooperative Studies Program (CSP) #465 study in the intensive group. | 118 | 892 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- The Long Term Effects of Intensive Glycemic Control in Type 2 Diabetes on the Secondary Outcome Cardiovascular Mortality.
- Description
The major secondary end-point of total mortality will measure all deaths with data retrieved from VA Information Resource Center (VIREC) Cooperate Data Warehouse (CDW) . Survival analysis will analyzed by time to death.
- Time frame
- 15 years
- Population
Total number of participants reflect all that participated in the VA Cooperative Studies Program (CSP) #465 study, Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT)NCT00032487, but censored those who refused to consent to 465 follow-up study or died or withdrew from the study.
Source ClinicalTrials.gov
Trial
- Title
- The VA Diabetes Trial Follow-up Study (VADT-FS)
- NCT number
- NCT00756613
- Phases
- Conditions
- Diabetes, Glycemic Control
- Interventions
- Lead sponsor
- VA Office of Research and Development
- Results first posted
- 2019-06-11
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT00756613?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT00756613-2bc5aa4e